Thousands of Illegal E-Cigarette Products in UK Seized

Dec.15.2022
Thousands of Illegal E-Cigarette Products in UK Seized
Thousands of non-compliant e-cigarette products have been removed in northeast England, with some confiscated devices not meeting safety standards.

The Trading Standards in the northeast of England, in cooperation with the Northeast Trade Standard Association, have taken thousands of non-compliant electronic cigarette products off the shelves. Over the past six months, a total of 1.4 tons of illegal disposable electronic cigarette products seized from retailers were sent for disposal.


All tobacco products, electronic cigarettes, and vaping devices must comply with strict tobacco control laws, including restrictions on nicotine content and container size. Some confiscated products had canisters that exceeded the legal limit by seven times, incorrect labeling, and devices lacking important health warnings, detailed batch information, and danger alerts.


Electronic cigarette devices must also display detailed information of the UK manufacturer or importer, who can be contacted in case of safety issues. A large number of unauthorized disposable electronic cigarettes have been seized for sale in the UK.


The majority of the work carried out by the Northeast England Trading Standards Association has been in response to concerns from consumers about children purchasing e-cigarette devices. In a test purchase operation conducted in March of this year on 32 retailers, 44% of them sold an e-cigarette device to an underage volunteer.


Ian Harrison, representing the Northeast England Trading Standards Association, has stated that electronic cigarettes pose a small portion of the risks associated with smoking, which have been found to cause two-thirds of lifelong smokers’ deaths. However, the number of electronic cigarette devices seized by trading standards suggests a significant market for non-compliant products. Consumers should be cautious when purchasing electronic cigarette products, and those interested in using them should opt for reputable e-cigarette shops.


John Herriman, CEO of the Accredited Standards Institute, expressed concern over the growing number of illegal activities surrounding the sale of electronic cigarettes. While acknowledging their potential as a smoking cessation tool, he also pointed out that many of these products are being sold to children, raising public concerns.


The trade standards team is undertaking important work in cracking down on unscrupulous retailers who sell these products to young people without the legally required age verification checks. It is crucial that e-cigarette products adhere to regulations put in place to protect public health and ultimately do not end up in the hands of children.


Ailsa Rutter OBE, Director of Fresh and Balance, stated that the best advice for smokers is to switch to e-cigarettes. However, non-smokers should not start smoking. E-cigarettes are much less harmful for smokers who want to quit, but it is important to ensure that the products being sold comply with UK regulations.


Ailsa Rutter OBE continued, "Smoking is still our biggest killer, with approximately 5,000 deaths due to addiction in our region every year, all of which are entirely preventable. We encourage any smokers considering quitting to try vaping, which can lower their risk of smoking-related diseases and premature death.


Electronic cigarette devices and electronic cigarettes must obtain approval from the Medicines and Healthcare products Regulatory Agency (MHRA) before they can be sold. Disposable electronic cigarettes that meet the requirements must have a maximum tank size of 2ml and a maximum nicotine strength of 20mg/ml or 2%. Electronic cigarette devices are age-restricted products and selling them to individuals under the age of 18 is illegal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Germany Probes 7.6 Million Illegal Vape Case With Estimated €33.3 Million Tax Loss; Four Chinese Manufacturer Employees Under Investigation, Some Packaging in Enforcement Images Resembles FUMOT Products
Germany Probes 7.6 Million Illegal Vape Case With Estimated €33.3 Million Tax Loss; Four Chinese Manufacturer Employees Under Investigation, Some Packaging in Enforcement Images Resembles FUMOT Products
German prosecutors and customs authorities are conducting a criminal investigation into an alleged cross-border organised vape network. Authorities say that between January 2024 and March 2025, four employees of an unnamed Chinese e-cigarette manufacturer allegedly built a network of sales agents and wholesalers that brought more than 7.6 million nicotine disposable vapes into Germany, causing an estimated €33.3 million in excise-tax losses. The manufacturer has not been named. Some products visible in enforcement images have packaging resembling products from FUMOT’s portfolio. European regulatory records from 2024, FUMOT’s public overseas-sales materials and records involving German vape importer and distribution company Zamu-Pro GmbH also show FUMOT/RandM products and German distribution activity during the period covered by the investigation.
Sep.21
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Jiangsu Provincial Medical Products Administration have issued a joint notice targeting illegal production and sales of vape products disguised as medical devices. The notice identifies six categories of violations, including obtaining medical licenses through false materials, misusing medical device credentials, expanding production beyond approved scopes, and using medical device-related online platforms to promote or sell vape products. The action is based on China’s tobacco and medical device regulations and aims to strengthen vape oversight and consumer protection.
Aug.04
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
The FDA authorized the JUUL2 device and tobacco- and menthol-flavored pods on Aug. 28, bringing the number of authorized e-cigarette products to 48. The agency highlighted complete switching among adult smokers, with six-week switching rates reaching 28.4%–49.3% for the menthol pod. The decision comes as FDA works to speed PMTA reviews, reduce application backlogs and expand authorized e-cigarette and nicotine-pouch products while maintaining enforcement priorities for unauthorized products.
Regulations
Aug.29
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Product | BAT Launches glo Hyper pro+ in Japan, Upgrading the Hyper Platform With Faster Start and Smart Device Management
Product | BAT Launches glo Hyper pro+ in Japan, Upgrading the Hyper Platform With Faster Start and Smart Device Management
British American Tobacco Japan (BAT Japan) has introduced glo Hyper pro+, an upgraded device within the existing glo Hyper platform. The device adds QuickStart™ rapid heating technology, an EasyView™ display and maintenance notification features to improve daily usability. Launched in Japan on July 13, 2026, glo Hyper pro+ maintains compatibility with existing Hyper-format tobacco sticks, including neo, Lucky Strike and KENT.
Jul.30
China STMA Deputy Administrator Meets KT&G COO as Heated Cigarette Rules Advance
China STMA Deputy Administrator Meets KT&G COO as Heated Cigarette Rules Advance
Wang Gongcheng, deputy administrator of China’s State Tobacco Monopoly Administration, met KT&G Chief Operating Officer Lee Sang-hak in Shanghai on September 1, according to Oriental Tobacco News. The meeting comes as China seeks public comment on a draft mandatory national standard for heated cigarettes. The report did not disclose the subjects discussed or indicate whether heated tobacco products or market access were addressed.
News
Sep.02